Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach.

Extensive evidence suggests that the self-assembly of amyloid-beta peptide (Aβ) is a nucleation-dependent process that involves the formation of several oligomeric intermediates. Despite neuronal toxicity being recently related to Aβ soluble oligomers, results from aggregation studies are often controversial, mainly because of the low reproducibility of several experimental protocols. Here a multimethodological study that included atomic force microscopy (AFM), transmission electron microscopy (TEM), fluorescence microscopy (FLM), mass spectrometry techniques (matrix-assisted laser desorption/ionization time-of-flight [MALDI-TOF] and electrospray ionization quadrupole time-of-flight [ESI-QTOF]), and direct thioflavin T (ThT) fluorescence spectroscopy were enabled to set up a reliable and highly reproducible experimental protocol for the characterization of the morphology and dimension of Aβ 1-42 (Aβ42) aggregates along the self-assembly pathway. This multimethodological approach allowed elucidating the diverse assembly species formed during the Aβ aggregation process and was applied to the detailed investigation of the mechanism of Aβ42 inhibition by myricetin. In particular, a very striking result was the molecular weight determination of the initial oligomeric nuclei by MALDI-TOF, composed of up to 10 monomers, and their morphology by AFM.

[1]  D. Kirschner,et al.  Alzheimer's beta-amyloid: insights into fibril formation and structure from Congo red binding. , 2005, Sub-cellular biochemistry.

[2]  Dong Jin Kim,et al.  Bis-styrylpyridine and bis-styrylbenzene derivatives as inhibitors for Abeta fibril formation. , 2007, Bioorganic & medicinal chemistry letters.

[3]  D. Selkoe Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. , 2001, Journal of Alzheimer's disease : JAD.

[4]  E. Bergantino,et al.  Conformational Equilibria in Monomeric α-Synuclein at the Single-Molecule Level , 2008, PLoS biology.

[5]  D. Butterfield,et al.  Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. , 2000, Journal of structural biology.

[6]  D. Pastré,et al.  Mica surface promotes the assembly of cytoskeletal proteins. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[7]  A. Takashima,et al.  Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease , 2003, Journal of neurochemistry.

[8]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[9]  T. Morgan,et al.  Vaccination with soluble Aβ oligomers generates toxicity‐neutralizing antibodies , 2001, Journal of neurochemistry.

[10]  S. Shimohama,et al.  Effects of nicotinic receptor agonists on beta-amyloid beta-sheet formation. , 1999, Japanese journal of pharmacology.

[11]  J. Cladera,et al.  Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation. , 2007, Biochemical and biophysical research communications.

[12]  D. Selkoe,et al.  Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.

[13]  T. Kihara,et al.  Multifunction of myricetin on Aβ: Neuroprotection via a conformational change of Aβ and reduction of Aβ via the interference of secretases , 2008 .

[14]  K. Davis,et al.  Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. , 2000, JAMA.

[15]  M. Hosokawa,et al.  Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. , 1989, Analytical biochemistry.

[16]  R. Kayed,et al.  Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct* , 2007, Journal of Biological Chemistry.

[17]  D. Middleton Solid-state NMR spectroscopy as a tool for drug design: from membrane-embedded targets to amyloid fibrils. , 2007, Biochemical Society transactions.

[18]  Min Zhu,et al.  Annular Oligomeric Amyloid Intermediates Observed by in Situ Atomic Force Microscopy* , 2004, Journal of Biological Chemistry.

[19]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[20]  D. Selkoe,et al.  Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. , 2004, Protein and peptide letters.

[21]  D. Selkoe,et al.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. , 1999, The Journal of biological chemistry.

[22]  V. Andrisano,et al.  Strategies for the Inhibition of Protein Aggregation in Human Diseases , 2010, Chembiochem : a European journal of chemical biology.

[23]  D. Selkoe,et al.  Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.

[24]  Peter T. Lansbury,et al.  Assembly of Aβ Amyloid Protofibrils: An in Vitro Model for a Possible Early Event in Alzheimer's Disease† , 1999 .

[25]  D. Teplow,et al.  Amyloid β-Protein Assembly and Alzheimer Disease* , 2009, Journal of Biological Chemistry.

[26]  S. Müller,et al.  Multiple Assembly Pathways Underlie Amyloid-β Fibril Polymorphisms , 2005 .

[27]  Nigel J Fullwood,et al.  Both the D-(+) and L-(-) enantiomers of nicotine inhibit Abeta aggregation and cytotoxicity. , 2004, Biochemistry.

[28]  D. Teplow,et al.  Amyloid beta-protein monomer folding: free-energy surfaces reveal alloform-specific differences. , 2008, Journal of molecular biology.

[29]  Alexander J. Rivest,et al.  Characterization of β amyloid assemblies in drusen: The deposits associated with aging and age-related macular degeneration , 2004 .

[30]  P. Lansbury,et al.  Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. , 1997, Chemistry & biology.

[31]  G. Bitan,et al.  Neurotoxic protein oligomers — what you see is not always what you get , 2005, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[32]  G. Schellenberg,et al.  Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.

[33]  W. Klein,et al.  Conformation‐dependent single‐chain variable fragment antibodies specifically recognize beta‐amyloid oligomers , 2009, FEBS letters.

[34]  Hai Lin,et al.  Imaging real-time aggregation of amyloid beta protein (1–42) by atomic force microscopy , 2002, Peptides.

[35]  M. Przybylski,et al.  Interaction of beta-amyloid(1-40) peptide with pairs of metal ions: An electrospray ion trap mass spectrometric model study. , 2009, Biophysical chemistry.

[36]  M. Kirkitadze,et al.  Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  W. B. Stine,et al.  The nanometer-scale structure of amyloid-Β visualized by atomic force microscopy , 1996 .

[38]  A. Murase,et al.  Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway. , 2009, The American journal of pathology.

[39]  I. Mook‐Jung,et al.  Aminostyrylbenzofuran derivatives as potent inhibitors for Abeta fibril formation. , 2008, Bioorganic & medicinal chemistry letters.

[40]  M. Findeis The role of amyloid β peptide 42 in Alzheimer's disease , 2007 .

[41]  E. Giralt,et al.  Fine structure study of Aβ1–42 fibrillogenesis with atomic force microscopy , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  T. Iwatsubo,et al.  Small Molecule Inhibitors of α-Synuclein Filament Assembly† , 2006 .

[43]  A. Cavalli,et al.  Insight Into the Kinetic of Amyloid β (1–42) Peptide Self‐Aggregation: Elucidation of Inhibitors’ Mechanism of Action , 2007, Chembiochem : a European journal of chemical biology.

[44]  R. Kayed,et al.  Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis , 2006, Neurology.

[45]  C. Bustamante,et al.  Substrate preparation for reliable imaging of DNA molecules with the scanning force microscope. , 1992, Ultramicroscopy.

[46]  R. Riek,et al.  3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .

[47]  F. Gejyo,et al.  Kinetic analysis of amyloid fibril formation. , 1999, Methods in enzymology.

[48]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[49]  B Urbanc,et al.  Elucidation of amyloid beta-protein oligomerization mechanisms: discrete molecular dynamics study. , 2010, Journal of the American Chemical Society.

[50]  E. Bergantino,et al.  The reaction of alpha-synuclein with tyrosinase: possible implications for Parkinson disease. , 2008, The Journal of biological chemistry.

[51]  D. Walsh,et al.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. , 1997, The Journal of biological chemistry.

[52]  G. Bitan,et al.  Amyloid β-protein: Monomer structure and early aggregation states of Aβ42 and its Pro19 alloform , 2005 .

[53]  M. Fändrich,et al.  The aggregation kinetics of Alzheimer's β‐amyloid peptide is controlled by stochastic nucleation , 2005, Protein science : a publication of the Protein Society.

[54]  P. Hough,et al.  High-resolution Atomic Force Microscopy of Soluble Aβ42 Oligomers , 2006 .

[55]  G. Bitan Structural study of metastable amyloidogenic protein oligomers by photo-induced cross-linking of unmodified proteins. , 2006, Methods in enzymology.

[56]  Peter T. Lansbury,et al.  Observation of metastable Aβ amyloid protofibrils by atomic force microscopy , 1997 .

[57]  L. Olsen,et al.  Study on the binding of Thioflavin T to β-sheet-rich and non- β-sheet cavities , 2007 .

[58]  W. Klein,et al.  Salvianolic acid B inhibits Aβ fibril formation and disaggregates preformed fibrils and protects against Aβ-induced cytotoxicty , 2008, Neurochemistry International.

[59]  T. Zako,et al.  Amyloid oligomers: formation and toxicity of Aβ oligomers , 2010, The FEBS journal.